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Objective: Findings from meta-analytic studies that use standardized
mean differences (SMDs) may be overly dependent on the original measures that
were used to generate SMDs. This may be particularly true when measures have
arbitrary metrics or when measures fail to meet measurement equivalence. We test
the hypothesis that in such cases, meta-analytic results may vary signiﬁcantly—
statistically and practically—as a function of the measures used to derive SMDs.
Methods: We conducted 5 secondary random-effects meta-analyses of SMDs—each
under a different measurement scenario—from a published meta-analysis comparing the efﬁcacy of cognitive–behavioral therapy with that of reminiscence therapy for depression in older adults. In each scenario, SMDs were based on scores
from measures with arbitrary metrics, some of which failed to meet measurement
equivalence. Results: Consistent with the hypothesis, meta-analysis results differed
signiﬁcantly—statistically and practically—between the measurement scenarios
under conditions of measurement nonequivalence. Conclusions: Results of metaanalyses involving measures with arbitrary metrics may depend on the measures
that the SMDs are based on when measurement equivalence fails to hold. Inferences concerning the relative efﬁcacy of different treatments can be measurement
dependent.
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A

s meta-analysis has become a preferred method for identifying evidencebased interventions (e.g., Murad, Asi, Alsawas, & Alahdab, 2016; Rubin & Bellamy, 2012), the number of published meta-analyses has increased rapidly
(Borenstein, Hedges, Higgins, & Rothstein, 2009; White, 2009). Often, different studies use different measures. Consequently, the meta-analyst must accumulate and
compare effect sizes (ESs) based on scores from different measures that frequently
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have arbitrary metrics (Kazdin, 2006). Blanton and Jaccard (2006, p. 27) deﬁne a metric as arbitrary “when it is not known where a given score locates an individual
on the underlying psychological dimension or how a one-unit change on the observed score reﬂects the magnitude of change on the underlying dimension.”
Unique to each scale (Lord & Novick, 1968), arbitrary metrics are problematic not
only because of their inherent uncertainties but also because the relationships between these metrics are unknown and thus, the scores cannot be directly compared
(Dorans, Pommerich, & Holland, 2010). Trying to directly compare them would be
like trying to compare the temperature in Town X (35 7C) with that in Town Y (95 7F)
without knowing the relationship between the units on the Fahrenheit and Celsius
scales—7F 5 (1.8  7C) 1 32—that facilitates the direct comparison (35 7C 5 95 7F).
The use of different measures in different studies and the associated score comparison problems led Lipsey and Wilson (2001) to frame the following question in
their introduction to meta-analysis:
With these quite different measures yielding different numerical values that
are meaningful only in relation to the speciﬁc operationalization and scales
used, how can their quantitative ﬁndings be encoded in a way that allows
them to be statistically combined and compared? (p. 4)
Lipsey and Wilson (2001, p. 4) emphasized that the answer to this question “relates
to an essential feature of meta-analysis, indeed, the feature that makes meta-analysis
possible and provides the hub around which the entire process revolves [emphasis added].”
Lipsey and Wilson’s (2001) answer to this question is that ESs are standardized.
Because ESs represent a statistical standardization of study ﬁndings, they are presumably interpretable in a consistent manner across all measures involved (Lipsey & Wilson, 2001). In the words of Grissom and Kim (2005, p. 49), this creates
“a measure of effect size that places different dependent variable measures on the same
scale [emphasis added].” This explanation suggests that ESs—such as the standardized mean difference (SMD), which is commonly used in treatment outcome studies—have taken the scores from different measures, with different and arbitrary
metrics, and transformed them into ESs expressed on the same numerical scale
in much the same way that the temperatures in Town X and Town Y can be converted
to the same temperature scale (e.g., 7F) using the relationship between the Fahrenheit and Celsius scales and then be compared.
For any construct of interest, a number (m) of measurement procedures ( j ) exist
( j 5 1, 2 . . . m; the measures are expressed as j 5 1, j 5 2 . . . j 5 m) and produce
scores that are inferred to represent the construct of interest. The number m can be
rather large; for example Mitchell (2010) identiﬁed 50 general depression scales.
The true SMD for Study i (i 5 1, 2 . . . n) based on scores from Measure j is symbolized by di( j); for example, the true SMD for Study 1 based on the scores from Mea-
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sure j 5 2 would be d1(2). In some cases, the true SMD for Study i may be based on
the average of g true SMDs; the true SMDs are based on scores from g (g ≤ m) of
the m measures (Borenstein et al., 2009). In this case, the true SMD would be symbolized by di(1, 2 . . . g) 5 avg[di(1), di(2) . . . di(g)] since this SMD is an average and
involves the true SMDs based on scores from the g measures. For example, say
the true SMD for Study 2 is the average of the true SMDs based on scores from
Measures j 5 1 and j 5 5. The true SMD for Study 2 would thus be symbolized
by d2(1, 5) 5 avg[d2(1), d2(5)]. Of course, the meta-analyst will not have the true
SMD for any study; rather, they will have an estimate of the true SMD. The estimate
of a true SMD will be symbolized the same way as the true SMD but with the lowercase d in place of the lowercase Greek d. Thus, for example, the estimated true
SMD for Study 1 based on the scores from Measure j 5 2 will be symbolized as
d1(2).
It is important to note that estimated SMDs for any study (i) based on the scores
from all measures (m) will almost certainly not be available to a meta-analyst; that
is, di(1), di(2) . . . di(m) will not all be available. Researchers select one or more measures for use in their studies based on considerations of their particular research
exigencies, and it is unlikely that all m measures will be used (especially if m is
large). To illustrate, suppose that a group of three studies is to be meta-analyzed
and that the outcome variable in these studies could, with justiﬁcation, have been
measured using any of four measures ( j 5 1 through j 5 4). This is illustrated in
Figure 1. In this ﬁgure, the left-hand column shows the measures used in Studies 1–
3 (above the line) as well as the estimated SMDs available to a meta-analyst for
each study (below the line). Measure j 5 1 was used in Study 1, Measures j 5 3
and j 5 4 were used in Study 2, and j 5 4 was used in Study 3; Measure j 5 2
was not used in any of the studies. This collection of measures used in the three
studies is called the measurement scenario for the three studies and is symbolized
as {( j 5 1)1, ( j 5 3, j 5 4)2, ( j 5 4)3}, where the measures used in the studies
are contained within parentheses and the subscript attached to each parenthesis
indicates the particular study. This measurement scenario leads to the estimated
SMDs—d1(1) for Study 1; d2(3), d2(4), and, possibly, avg[d2(3), d2(4)] for Study 2; and
d3(4) for Study 3—that are available to the meta-analyst. In Figure 1, the right-hand
column shows, above the line, the measures not used in the studies; the estimated
SMDs not available to the meta-analyst are shown below the line. Because Measures
j 5 2, j 5 3, and j 5 4 were not used in Study 1; j 5 1 and j 5 2 were not used
in Study 2; and j 5 1, j 5 2, and j 5 3 were not used in Study 3, any estimated SMDs
based on scores from these measures are unavailable to a meta-analyst. These inestimable SMDs are a form of what Gilovich (1991) called absent data—in this case,
estimated SMDs that cannot be computed and hence are unavailable to the metaanalyst. This scenario readily generalizes to circumstances in which there are m
reasonable measures and n studies.
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Figure 1. Illustration of hypothetical measurement scenario for three studies. The left-hand column shows
measures actually used in the hypothetical studies, and the right-hand column shows the measures not used
in the hypothetical studies. The estimated SMDs below the line in the right-hand column are absent data.
SMD 5 standardized mean difference.

If arguments by methodologists such as Lipsey and Wilson (2001) and Grissom
and Kim (2005)—that the standardization inherent in the SMD places estimated
true SMDs on the same scale—are assumed to be correct, then the true SMD for
Study i based on scores from Measure j 5 1, di(1) will be equal to that for Study i
based on the scores from a different measure—j 5 2, di(2)—even if the metrics of
j 5 1 and j 5 2 are arbitrary, different, and the relationship between them is unknown. Similarly, the estimated true SMDs di(1) and di(2) will be on the same scale
and will therefore be statistically interchangeable since, although they will differ
due to sampling variability, they will nonetheless be estimates of the same true
SMD. Consequently, all measurement scenarios will be statistically interchangeable
and the results of meta-analyses of the n studies will be the same, within limits of
sampling variability, across all possible measurement scenarios involving the m measures. It will not matter which measures are used in which studies. This is, theoretically, what makes meta-analysis so informative and valuable for research synthesis.
It has been argued that true SMDs for Study i based on scores from two measures
( j 5 1 and j 5 2) will be equal only when two measurement conditions—construct
equivalence and equal reliabilities—simultaneously hold for the scores from Measures
j 5 1 and j 5 2 in all subpopulations of a population of interest (Nugent, 2012). The
construct equivalence condition is formally expressed by Equation 1,

The Existence of Measurement Dependence

T1 5 ðF12  T2 Þ 1 H12 ,

165

(1)

where Τ1 and Τ2 represent the true scores on Measures j 5 1 and j 5 2, respectively,
and F12 and H12 represent real-number parameters deﬁning the relationship between the metrics of Τ1 and Τ2. Conceptually, this relationship implies that the
scores from Measures j 5 1 and j 5 2 represent the exact same construct ( Joreskog,
1971). The equal reliabilities condition asserts that the reliability coefﬁcients for
the scores from Measures j 5 1 and j 5 2 are equal. The conjunction of construct
equivalence and equal reliabilities deﬁnes a form of measurement equivalence,
stated conceptually as Measures j 5 1 and j 5 2 produce scores representing the exact same
construct, with the exact same reliability, in all subpopulations of the population of interest.
For the sake of brevity, we will hereafter refer to the term “the conjunction of construct equivalence and equal reliabilities” as CE (for construct equivalence) and
ER (for equal reliabilities), or CE and ER.
If CE and ER does not hold—particularly if CE fails to hold—the scores from one
or more of the m measures will not represent the exact same construct with the
same reliability (Solow, 2002). Thus, vectors of estimated SMDs input into a metaanalysis can differ statistically. Consequently, meta-analytic results can differ based
on which vectors of estimated SMDs are input into the meta-analysis, and thus which
measures are used in which studies. Nugent (2012, 2013) argued that the greater the
extent to which the estimated SMD for any study (i) in a group of n studies differs
between measurement scenarios as a consequence of violations of CE and ER,
and the larger the fraction of the n studies for which these large differences exist,
the greater the likelihood that results of a meta-analysis of the studies will differ
between measurement scenarios and, therefore, be measurement dependent.

The Current Study
The current study augments previous research by empirically demonstrating the measurement dependence of meta-analytic results. Nugent (2013) conducted a modelbased simulation showing that violation of the CE condition can lead to large differences between di(1) and di(2) for Study i, and that simultaneous violations of CE
and ER can lead not only to greater differences between di(1) and di(2) for Study i
but also to different rank orderings of these true SMDs for the same pair of studies. More recently, Nugent (2017) conducted a Monte Carlo simulation testing the
conjecture that meta-analytic results can vary as a consequence of true SMDs based
on scores from measures that violate CE. Findings suggested that violations of CE
can lead to contradictory results in a meta-analysis of the same set of studies. The results of these model-based simulations can be considered as hypotheses, or predictions, that require empirical veriﬁcation (Banks, 2009; Harrison, Carroll, & Carly,
2007). However, no empirical studies have investigated whether the results of actual
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meta-analyses may be measurement dependent. The current study addresses this
absence.

Method
The secondary analyses in this study were of estimated SMDs comparing treatments
for depression in older adults; the estimated SMDs were from eight studies of randomized clinical trials that were included in a systematic review conducted by Peng,
Huang, Chen, and Lu (2009). The secondary meta-analyses involved 11 comparisons of the efﬁcacy of types of cognitive–behavioral therapy (e.g., problem-solving
therapy, cognitive and behavioral bibliotherapy, and cognitive and behavioral selfmanagement)—the various forms of which we will subsequently refer to as “cognitive–
behavioral therapy”—and various forms of reminiscence therapy, which we will
henceforth refer to as “reminiscence therapy.” Seven of the studies compared
cognitive–behavioral therapy with waiting-list control or delayed treatment, and four
studies compared reminiscence therapy with waiting list control or delayed treatment. We will subsequently refer to the waiting-list control and delayed-treatment
conditions as “no treatment.” We included a single estimated SMD for the direct
comparison of cognitive–behavioral therapy with reminiscence therapy by Arean
and colleagues (1993) because this estimated SMD was correlated with two others
from this study, and this inclusion brought the information contained in these covariances into analyses (Gleser & Olkin, 2009). Readers are referred to Peng et al.
(2009) for details of this systematic review and meta-analysis.

Measures
The measures used in the eight studies included in the secondary meta-analyses
were the Beck Depression Inventory (Beck, Steer, & Garbin, 1988); the Center for
Epidemiologic Studies Depression scale (Radloff, 1977); the Hamilton Rating Scale
(Hamilton, 1960); the Geriatric Depression Scale (Sheikh & Yesavage, 1986); and the
Brief Symptom Inventory depression subscale (Derogatis & Melisarotos, 1983). All of
these frequently used and well-known measures have arbitrary metrics. Three measures were used in three of the studies, two were used in three of the studies, and one
was used in two of the studies. Table 1 displays the measures upon which the estimated SMDs were based in the current study.

Estimated SMDs
Each of the authors independently computed the estimated SMDs for treatment
comparisons and then compared results. There was 100% agreement for the SMD
estimates. We computed the estimated SMDs from information in the published
studies using formulas from Borenstein et al. (2009) and Gleser and Olkin (2009).
The estimated true SMD for a treatment/no-treatment comparison from Study i based
on scores from Measure j was estimated by
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(2)

 jÞg1 was the sample mean score on the dependent variable for Group 1 and
where Yð
 jÞg2 was the sample mean score on the dependent variable for Group 2, based on
Yð
scores from Measure j. Also, sp( j) was the pooled sample standard deviation based
on scores from Measure j, given by
sﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
 

ðng1 2 1Þ  s2 ð jÞg1 1 ðng2 2 1Þ  s2 ð jÞg2
s p ð jÞ 5
,
ng1 1 ng2 2 2

(3)

where ng1 was the sample size of Group 1 and ng2 was the sample size for Group 2;
s2( j)g1 was the sample variance of scores for Group 1 and s2( j)g2 was the sample variance of scores for Group 2, based on the scores from Measure j. These estimated
SMDs were corrected for small-sample bias by multiplying them by
J 512

3
:
4ðng1 1 ng2 2 2Þ 2 1

(4)

We estimated the small-sample bias-corrected variances of sample estimates of di( j)—
symbolized as var[di( j)]—by



1
1
d2i ð jÞ
var½di ð jÞ 5 J 
,
1
1
ng1 ng2 2  ntotal
2

(5)

where ntotal was the total number of people in the study (Gleser & Olkin, 2009).
In studies in which multiple treatments were compared with a common notreatment group, the values of di( j) for treatment group versus no-treatment group
comparisons were correlated due to sharing the same no-treatment group (Gleser &
Olkin, 2009; Higgins & Green, 2011). We computed the covariance between estimates of di( j) in these cases—symbolized as cov(di( j)tx1, di( j)tx2)—from
covðdi ð jÞtx1 , di ð jÞtx2 Þ 5

1 di ð jÞtx1  di ð jÞtx2
1
,
nc
2  ntotal

(6)

where nc was the number of people in the shared no-treatment group, and di( j)tx1 and
di( j)tx2 were the estimated SMDs based on scores from Measure j for comparing Treatment 1 (tx1) with the common no-treatment group and Treatment 2 (tx2) with the
common no-treatment group, respectively (Gleser & Olkin, 2009).
In three of the ﬁve measurement scenarios described later, we estimated unweighted mean SMDs for studies in which multiple measures were used. We computed the variances of these estimated SMDs using Equation 24.5 from Borenstein
et al. (2009, p. 230). In the interest of clarity, this complex formula is shown here
using the symbolism we deﬁned earlier. For an estimated SMD that was the average
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Rokke et al. (1999)—CBT vs. ntx

Mastel-Smith, McFarlane, Sierpina,
Malecha, A., & Haile (2007)—RT vs. ntx
Rokke, Tomhave, & Jocic (1999)—
CBT vs. ntx

Floyd, Scogin, McKendree-Smith,
Floyd, & Rokke (2004)—CBT vs. ntx

Arean et al. (1993)—RT vs. ntx

Arean et al. (1993)—CBT vs. ntx

Study and Treatments Compared

BSI-D
d9(BSI-D)
BDI, GDS, HRS
avg[d3(HRS), d3(GDS),
d3(BDI)]
BDI, GDS, HRS
avg[d4(HRS), d4(GDS),
d4(BDI)]

HRS*
d1(HRS)

HRS, GDS, BDI
avg[d1(HRS), d1(GDS),
d1(BDI)]
HRS, GDS, BDI
avg[d8(HRS), d8(GDS),
d8(BDI)]
HRS, GDS
avg[d2(HRS), d2(GDS)]

HRS*
d4(HRS)

BSI-D
d9(BSI-D)
HRS*
d3(HRS)

HRS
d2(HRS)

GDS
d8(HRS)

Measurement
Scenario 2A

Measurement
Scenario 1

BDI*
d4(BDI)

BSI-D
d9(BSI-D)
BDI*
d3(BDI)

GDS
d2(GDS)

HRS
d8(BDI)

BDI*
d1(BDI)

Measurement
Scenario 2B

HRS, GDS
avg[d2(HRS),
d2(GDS)]
BSI-D
d9(BSI-D)
GDS and HRS**
avg[d3(HRS),
d3(GDS)]
GDS, HRS
avg[d4(HRS),
d4(GDS)]

HRS, GDS, BDI
d8(HRS)

HRS**
d1(HRS)

Measurement
Scenario 3A

Table 1
Studies, Treatment Comparisons, Measures, and Symbolic Representations of Estimated SMDs Included in the Secondary Meta-Analyses

BDI
d4(BDI)

HRS, GDS
avg[d2(HRS),
d2(GDS)]
BSI-D
d9(BSI-D)
BDI**
d3(BDI)

HRS, GDS, BDI
avg[d8(GDS), d8(BDI)]

GDS and BDI**
avg[d1(GDS), d1(BDI)]

Measurement
Scenario 3B
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HRS, GDS, BDI
avg[d7(HRS), d7(GDS),
d7(BDI)]
HRS, GDS
avg[d5(GDS), d5(HRS)]
HRS, GDS
avg[d6(GDS), d6(HRS)]
CES-D
d10(CES-D)
GDS
d11(GDS)

Measurement
Scenario 1
BDI*
d7(BDI)
GDS*
d5(GDS)
GDS*
d6(GDS)
CES-D
d10(CES-D)
GDS
d11(GDS)

HRS*
d5(HRS)
HRS*
d6(HRS)
BDI
d10(CES-D)
GDS
d11(GDS)

Measurement
Scenario 2B

HRS*
d7(HRS)

Measurement
Scenario 2A

HRS**
d5(HRS)
HRS**
d6(HRS)
CES-D, BDI
d10(CES-D)
GDS
d11(GDS)

HRS**
d7(HRS)

Measurement
Scenario 3A

GDS**
d5(GDS)
GDS**
d6(GDS)
CES-D, BDI
d10(CES-D)
GDS
d11(GDS)

GDS and BDI**
avg[d7(GDS), d7(BDI)]

Measurement
Scenario 3B

Note. Symbolic representations of estimated true standardized mean differences (SMDs) are indicted in bold type. For example, d1(BDI) is the estimated
true SMD for Study 1 (Arean et al., 1993) based on scores from the Beck Depression Inventory (BDI). BSI-D 5 Brief Symptom Inventory depression subscale;
CES-D 5 Center for Epidemiologic Studies Depression scale; CBT 5 cognitive–behavioral therapy; GDS 5 Geriatric Depression Scale; HRS 5 Hamilton
Rating Scale; ntx 5 no treatment; RT 5 reminiscence therapy.
* Estimated SMDs are statistically different between Measurement Scenarios 2A and 2B
** Estimated SMDs are statistically different between Measurement Scenarios 3A and 3B.

Serrano, Latorre, Gatz, & Montanes
(2004)—RT vs. ntx
Wang, Hsu, & Cheng (2005)—RT vs. ntx

Scogin, Jamison, & Gochneaur (1989)—
CBT vs. ntx
Scogin et al. (1989)—CBT vs. ntx

Scogin, Hamblin, & Beutler (1987)—
CBT vs. ntx

Study and Treatments Compared

Table 1 (continued)
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of three estimated SMDs—say, di(1), di(2), and di(3)—based on scores from Measures
j 5 1, j 5 2, and j 5 3, this formula is
 2
1
fvar½di ð1Þ 1 var½di ð2Þ 1 var½di ð3Þ
3
pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃpﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃpﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 2rj51, j52 var½di ð1Þ var½di ð2Þ 1 2rj51, j53 var½di ð1Þ var½di ð3Þ
pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃpﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 2rj52, j53 var½di ð2Þ var½di ð3Þg,
varfavg½di ð1Þ, di ð2Þ, di ð3Þg 5

(7)

where rj 5 1, j 5 2 is the correlation between the scores on Measures j 5 1 and j 5 2,
and similarly for the correlations rj 5 1, j 5 3 and rj 5 2, j 5 3. If there were only two measures—for instance, j 5 1 and j 5 2—the terms involving rj 5 1, j 5 3 and rj 5 2, j 5 3 drop
out of this equation; the multiplicative term at the front of the right-hand side of
this formula would be (1/2)2. Because estimates of these correlations were not reported in any of the studies in the Peng et al. (2009) meta-analysis, per Borenstein
et al. (2009), we conducted analyses for upper and lower ends of a range of plausible values of the correlations, speciﬁcally .90 and .70. In the interest of brevity, we
are reporting only the results assuming the correlations were .90.

Tests of Construct Equivalence and Equal Reliabilities
Hedges and Olkin (1985, pp. 210–212) described a test of the null hypothesis for a
study (i) in which g different measures were used to measure the dependent variable:
H0 : di ð1Þ 5 di ð2Þ 5 ::::: 5 di ð gÞ 5 di:

(8)

Expressed in words, this null hypothesis states: The estimated population of true
SMDs for Study i based on the scores from the g measures of presumably the same
construct used in Study i is an estimate of a mutual (i.e., the same) SMD (di). The alternate hypothesis (H1) is that one or more of the g estimated SMDs for Study i based
on scores from the g measures is not an estimate of the mutual true SMD (di). We used
this method to test the plausibility that CE and ER held for the scores from the g 5 2
or g 5 3 measures upon which estimated SMDs were based in studies using multiple
measures of depression. Statistically nonsigniﬁcant results of this test would suggest
it was plausible to assume that CE and ER held for the scores from the g measures
used in the study; statistically signiﬁcant results would suggest it was plausible to assume CE and ER did not hold.
We computed the chi-square statistic for this test using the matrix equation
(the letters in bold type indicate matrices; see Equation 7 in Hedges & Olkin, 1985,
p. 211),
x2 ð g 2 1Þ 5 dT Md,

(9)

where g was the number of measures (and estimated SMDs) in the study, d was a column vector of estimated SMDs for the given study based on the scores from the g dif-
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ferent depression measures, and dT was the transpose of this column vector. In this
equation,


M 5 L – 1=eT Le LeeT L,
(10)
L was the inverse of the variance–covariance matrix for the g estimated SMDs for
Study i based on the scores from the different measures, and e was a column vector
of ones, the number of which was equal to g; eT was the transpose of this vector
(see Equation 8 in Hedges & Olkin, 1985, p. 211).
The variance–covariance matrix of the g estimated SMDs (∑g) was estimated by
^ g 5 DRD,
Σ

(11)

(Hedges & Olkin, 1985, p. 211), where D was a diagonal matrix (the elements of
which were the estimated standard deviations of the estimates of the true SMDs
given by the square root of Equation 5), and R was the matrix of correlations between the scores from the g different measures used in Study i. Assuming a range
of plausible correlations from .70–.90, we computed the chi-square statistics at values of .70 and .90. If the results of the chi-square test produced statistically significant results at a correlation of either .70 or .90, we inferred that it was plausible
that the SMDs were based on scores from different measures that failed to meet CE
and ER.
We used a two-step procedure. First, we conducted an omnibus test, which tested
the null hypothesis that at least one of the g estimated SMDs was based on scores
that failed to meet CE and ER. If this test was statistically signiﬁcant, then we conducted pair-wise tests to determine which estimated SMDs were based on scores failing to meet CE and ER.

Measurement Scenarios
Our general scheme was to create measurement scenarios meeting the conditions
that Nugent (2013) identiﬁed as most likely to lead to different meta-analytic outcomes as a consequence of measurement nonequivalence. Thus, measurement scenarios were created such that
• sizable percentages of large, statistically signiﬁcant differences existed between the estimated SMDs for given treatment/no-treatment comparisons
between scenarios but based on different measures in the studies included
in Peng et al.’s (2009) meta-analysis; and
• if there were multiple treatment/no-treatment comparisons in a study, the
estimated SMDs for all comparisons were based on scores from the same
measure or average of measures. We considered it unlikely that a researcher
would use one measure, or combination of measures, for a treatment/no-
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treatment comparison, but then use a different measure, or combination of
measures, for a second such comparison within the same study.
Measurement Scenario 1. The estimated SMD for a given treatment/no-treatment
comparison in this scenario was the average across the g estimated SMDs based on
scores from the g measures used in the study. Symbolic representations of the estimated SMDs and the measures they were based on in this scenario are shown in
Table 1.
Measurement Scenarios 2A and 2B. These scenarios exempliﬁed circumstances in
which researchers used only a single measure of depression in their study. The measures that estimated SMDs were based on, and symbolic representations of the estimated SMDs in these scenarios, are shown in Table 1. For comparisons of cognitive–
behavioral therapy with no treatment, we created these scenarios as follows:
• If a study included a single comparison of cognitive–behavioral therapy
with no treatment, we used the largest estimated SMD in Scenario 2A and
the smallest in Scenario 2B.
• If a study compared two forms of cognitive–behavioral therapy with no
treatment, we used the largest SMDs for the two treatments based on the
same measure in Scenario 2A, and we used the smallest based on the same
measure in Scenario 2B.
For comparisons of reminiscence therapy with no treatment:
• For any study in which only reminiscence therapy was compared with no
treatment, if there was a single estimated SMD based on a single measure,
we used that SMD in Scenarios 2A and 2B.
• For the study in which both reminiscence therapy and cognitive–behavioral
therapy were compared with no treatment (Arean et al., 1993), the SMD for
reminiscence therapy used in Scenario 2A was based on the same measure
as that for cognitive–behavioral therapy. The SMD for reminiscence therapy
used in Scenario 2B was based on the same measure as that for cognitive–
behavioral therapy.
Of the seven estimated SMDs for comparing cognitive–behavioral therapy with no
treatment in Scenario 2A, 86% were larger than the corresponding SMDs for the
same comparison in Scenario 2B to statistically signiﬁcant levels (see Table 2). The
differences between Scenarios 2A and 2B embodied Nugent’s (2012, 2013) measurement condition likely to lead to differing meta-analytic results.
Measurement Scenarios 3A and 3B. The measures that the estimated SMDs were
based on, and symbolic representations of the estimated SMDs in these scenarios,
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are shown in Table 1. These estimates incorporated all measures by using averages
of SMDs based on scores from measures that appeared to meet CE and ER as indicated by results of the Hedges and Olkin (1985) tests. For comparisons of cognitive–
behavioral therapy with no treatment, we created these measurement scenarios as
follows:
• If there were two estimated SMDs for a cognitive–behavioral therapy/no
treatment comparison based on scores from two different measures, and
if these two did not differ to a statistically signiﬁcant degree, we used the
average of the two in Scenarios 3A and 3B.
• If there were two estimated SMDs for a cognitive–behavioral therapy/no
treatment comparison based on scores from two different measures, and
if these two did differ statistically, we used the larger of the two in Scenario 3A, and we used the smaller in Scenario 3B.
We used a slightly more complicated procedure (illustrated in Figure 2) if there
were three estimated SMDs for a comparison of cognitive–behavioral therapy with
no treatment:
• If one of the SMDs for a cognitive–behavioral therapy/no-treatment comparison differed from the other two to a statistically signiﬁcant degree and the
other two did not, the other two were averaged. We used whichever was
larger—the single SMD or the average of the two—in Scenario 3A and used
the smaller in Scenario 3B.
• To maintain consistency in the measures used for the cognitive bibliotherapy/
no-treatment comparison in the Rokke, Tomhave, and Jocic (1999) study,
the SMDs in Scenarios 3A and 3B were based on the same measures that
the SMDs for the behavioral bibliotherapy/no-treatment comparison were
based on.
For comparisons of reminiscence therapy with no treatment:
• For any study in which only reminiscence therapy was compared with no
treatment, if there was a single estimated SMD based on a single measure,
we used that SMD in Scenarios 3A and 3B.
• For the study in which both reminiscence therapy and cognitive–behavioral
therapy were compared with no treatment (Arean, et al., 1993),
○ the SMD for reminiscence therapy used in Scenario 3A was based on
the same single measure as the SMD for cognitive–behavioral therapy
in 3A, and
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Rokke et al. (1999)—CBT vs. ntx

Arean et al. (1993)—RT vs. ntx
Floyd et al. (2004)—CBT vs. ntx
Mastel-Smith et al. (2007)—RT vs. ntx
Rokke et al. (1999)—CBT vs. ntx

Arean et al. (1993)—CBT vs. ntx

Study and Treatment

Omnibus test, v2(2) 5 107.6, p < .05
SMDs based on HRS and BDI differ, v2(1) 5 87.5, p < .05;
SMDs based on HRS and GDS differ, v2(1) 5 81.1, p < .05;
SMDs based on BDI and GDS do not differ, v2(1) 5 .006, p > .05;
SMD based on HRS differed from mean SMD based on GDS and BDI, x2(1) 5 85.8, p < .05.
Omnibus test, v2(2) 5 3.42, p > .05
Omnibus test, v2(1) 5 2.99, p > .05
Only a single estimated SMD based on scores from BSI-D.
Omnibus test, v2(2) 5 9.44, p < .05
SMDs based on BDI and HRS differ, v2(1) 5 6.69, p < .05;
SMDs based on GDS and BDI differ, v2(1) 5 4.46, p < .05;
SMDs based on GDS and HRS do not differ, v2(1) 5 .02, p > .05;
SMD based on BDI differed from mean SMD based on GDS and HRS, x2(1) 5 41.4, p < .05.
Omnibus test, v2(2) 5 9.86, p < .05
SMDs based on GDS and HRS differ, v2(1) 5 9.86, p < .05;
SMDs based on BDI and HRS do not differ, v2(1) 5 2.73, p > .05;
SMDs based on GDS and BDI do not differ, v2(1) 5 2.24, p > .05;
SMD based on BDI did not differ from mean SMD based on GDS and HRS, x2(1) 5 .007, p > .05.

Results of Tests of Homogeneity of SMDs Based on Scores From Different Measures

Table 2
Results of Hedges and Olkin (1985) Tests of Construct Equivalence and Equal Reliabilities
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Omnibus test, v2(2) 5 9.31, p < .05
SMDs based on HRS and GDS differ, v2(1) 5 5.90, p < .05;
SMDs based on HRS and BDI differ, v2(1) 5 8.75, p < .05;
SMDs based on GDS and BDI do not differ, v2(1) 5 0.24, p > .05;
SMD based on HRS differed from mean SMD based on GDS and BDI, x2(1) 5 6.88, p < .05.
Omnibus test, v2(1) 5 41.55, p < .05
The two estimated SMDs based on different measures differed statistically.
Omnibus test, v2(1) 5 38.32, p < .05
The two estimated SMDs based on different measures differed statistically.
Only a single estimated SMD based on scores from CES-D.
Only a single estimated SMD based on scores from GDS.

Results of Tests of Homogeneity of SMDs Based on Scores From Different Measures

Note. BDI 5 Beck Depression Inventory; BSI-D 5 Brief Symptom Inventory depression subscale; CBT 5 cognitive–behavioral therapy; CES-D 5
Center for Epidemiologic Studies Depression scale; GDS 5 Geriatric Depression Scale; HRS 5 Hamilton Rating Scale; ntx 5 no treatment;
RT 5 reminiscence therapy.

Serrano et al. (2004)—RT vs. ntx
Wang et al. (2005)—RT vs. ntx

Scogin et al. (1989)—CBT vs. ntx

Scogin et al. (1989)—CBT vs. ntx

Scogin et al. (1987)—CBT vs. ntx

Study and Treatment

Table 2 (continued)
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Figure 2. Illustration of the procedure used to create Measurement Scenarios 3A and 3B when there were
three measures used in a study and there were three estimated standardized mean differences (SMDs) for
each comparison of a form of cognitive–behavioral therapy with no treatment.

○ the SMD used in Scenario 3B was the average of two SMDs based
on the same two measures that the averaged SMD for cognitive–
behavioral therapy was based on.
Of the seven estimated SMDs comparing cognitive–behavioral therapy with no treatment in Scenario 3A, 71% were statistically larger than the corresponding SMDs
in Scenario 3B (see Table 2). This condition exempliﬁed Nugent’s (2012, 2013) condition likely to lead to differing meta-analytic results between scenarios. Scenarios 3A
and 3B were conceived as a generalization of 2A and 2B; the estimated SMDs in 3A
and 3B included SMDs that were averages of SMDs based on scores from different
measures that appeared to meet CE and ER.

Analysis Methods
We used random effects analysis methods (Borenstein et al., 2009) given the different forms of cognitive–behavioral therapy and reminiscence therapy involved in
the studies included in Peng et al.’s (2009) meta-analysis. The weighted regression
methods for multiple treatment studies described by Gleser and Olkin (2009) were
used as well. The estimated mean SMDs for cognitive–behavioral therapy as com-
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pared with no treatment, for reminiscence therapy as compared with no treatment,
and the differences between these means, were estimated using the weighted regression model,
 T 21 T
X Ld,
dc
m 5 X LX

(12)

where dc
m was the column vector of estimated mean SMDs for the treatment effects,
d was the column vector of sample estimated SMDs for the different treatment comparisons, and X was the design matrix composed of dummy variables indicating
treatment. The transpose of the design matrix was
0

1 0 0 0 0 0 0 0 0 0 0 0

1

C
B
C
B
X T 5 B 0 1 0 1 0 1 1 1 1 0 0 1 C,
A
@
0 0 1 0 1 0 0 0 0 1 1 0

(13)

where the ones in the ﬁrst row in XT indicated direct comparison of cognitive–
behavioral therapy with reminiscence therapy; the ones in the second row indicated
comparison of cognitive–behavioral therapy with no treatment; and the ones in the
third row indicated comparison of reminiscence therapy with no treatment. As noted
earlier, we included this single direct comparison of cognitive–behavioral therapy
with reminiscence therapy (Arean et al., 1993) in order to infuse into the analyses
the information contained in the covariances between this study’s estimated SMD
and the two other estimated SMDs. (The results for this single direct comparison
are not described here because they were based on a single study.) Finally, we computed the Q-statistics needed for estimating s2 (the variance of true SMDs) and I2 (the
ratio of true heterogeneity to total variance of observed SMDs; Borenstein, 2009) for
these analyses from
T T
c
Q 5 dT Ld 2 dc
m X LXdm ,

(14)

T
where dc
m was the transpose of the column vector from Equation 12.

Practical Signiﬁcance
We assessed the practical signiﬁcance of the magnitude of estimated mean SMDs—and
the practical signiﬁcance of the estimated differences between them—by comparing the estimated mean SMDs to the mean (.47) and standard deviation (SD 5 .28)
of Lipsey and Wilson’s (1993) “reﬁned” distribution of mean ESs from 156 metaanalyses of 9,400 treatment-effectiveness studies (see Lipsey & Wilson, 1993, Figure 7, p. 1198). Lipsey and Wilson stated that this reﬁned distribution had better
statistical properties than a more inclusive distribution of mean ESs from 302 metaanalyses (1993, Figure 1, p. 1192).
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Meta-Analytic Research Questions and Hypotheses
In the current study, we conducted analyses to address three meta-analytic questions:
1. What was the efﬁcacy of cognitive–behavioral therapy as compared with
no treatment for decreasing depression in older adults, and what was the
magnitude of this treatment effect?
2. What was the efﬁcacy of reminiscence therapy as compared with no treatment for decreasing depression in older adults, and what was the magnitude of this treatment effect?
3. What was the efﬁcacy of cognitive–behavioral therapy as compared with
no treatment—relative to the efﬁcacy of reminiscence therapy as compared
with no treatment—for decreasing depression in older adults, and what
was the difference between the magnitudes of these treatment effects?
The latter research question indirectly addressed comparison of the efﬁcacy of cognitive–behavioral therapy with that of reminiscence therapy; if one treatment was
more efﬁcacious than the other, then the SMDs representing the efﬁcacy of that
treatment relative to no treatment should be larger in magnitude than those representing the efﬁcacy of the other treatment relative to no treatment. Measurement
Scenarios 2A and 2B, 3A and 3B, 2A and 3B, and 3A and 2B were not interchangeable; however, 2A and 3A and 2B and 3B were interchangeable.

Results
Results of Tests of CE and ER
The results of Hedges and Olkin (1985) tests, shown in Table 2, suggested that SMDs
based on scores from different measures failed to meet CE and ER for six of the
seven comparisons of cognitive–behavioral therapy with no treatment. In contrast,
the scores from all the measures that the estimated SMDs for comparisons of reminiscence therapy with no treatment were based on appeared to meet CE and ER.
For example, as shown in Table 2, the results of the omnibus test for differences between the estimated SMDs in the Arean et al. (1993) study for comparing cognitive–
behavioral therapy with no treatment based on scores from the Hamilton Rating
Scale, Geriatric Depression Scale, and Beck Depression Inventory was v2(2) 5 107.6,
p < .05, suggesting that at least one of the estimated SMDs was not an estimate of
a shared true SMD. Results of follow-up pair-wise comparisons indicated that the
estimated SMD based on the Hamilton Rating Scale differed from the estimated
SMD based on the Geriatric Depression Scale—v2(1) 5 81.1, p < .05—and the estimated SMD based on the Beck Depression Inventory—v2(1) 5 87.5, p < .05. The estimated SMDs based on the Geriatric Depression Scale and the Beck Depression Inventory did not differ beyond what is expected if both were estimates of a mutual
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true SMD, v2(1) 5 0.006, p > .05. Finally, the estimated SMD based on the Hamilton
Rating Scale differed statistically from the average of the estimated SMDs based
on the Geriatric Depression Scale and the Beck Depression Inventory, v2(1) 5
85.8, p < .05.

Results for Different Measurement Scenarios
The results for the different measurement scenarios are illustrated in Figure 3.
Results for Measurement Scenario 1. The estimated variance of true SMDs (s2)
was .074, s 5 .272, and the estimated I2 was 38.7%. The mean SMD for cognitive–
behavioral therapy as compared with no treatment was 2.92, with Z 5 24.86, p <
.05, 95% CI [21.29, 20.55]. The mean SMD for reminiscence therapy as compared
with no treatment was 20.55, with Z 5 22.77, p < .05, 95% CI [20.94, 20.16].

Figure 3. Results for estimated mean standardized mean differences (SMDs) for comparing cognitive–
behavioral therapy (CBT) with no treatment (circular points); for comparing reminiscence therapy (RT)
with no treatment (diamond-shaped points); and estimated differences between mean SMDs for comparing CBT with no treatment and mean SMDs for comparing RT with no treatment (X markers). The vertical bars show 95% conﬁdence intervals. Numbers in italicized and bold type in parentheses show the
number of SDs of the reﬁned Lipsey and Wilson (1993) distribution that a difference between estimated
mean SMDs represents. The brackets above each partitioned section of the graph indicate the different
comparisons made. The alphanumeric labels in the ﬁgure indicate the measurement scenarios that the results
are based on. A minus sign on an estimated mean SMD, or difference between estimated mean SMDs,
indicates that the treatment reduces depression to a greater degree than no treatment, while a positive sign
indicates the reverse. ES 5 effect size.
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The difference between the mean SMD for comparing cognitive–behavioral therapy
with no treatment and that for comparing reminiscence therapy with no treatment
was 2.40, with Z 5 21.50, p > .05, 95% CI [20.92, 0.12]. This statistically nonsignificant difference covered about 1.4 SDs in the Lipsey and Wilson (1993) reﬁned distribution.
Results for Measurement Scenario 2A. The estimated s2 was .144, s 5 .379, and the
estimated I2 was 55.1%. The estimated mean SMD for cognitive–behavioral therapy
as compared with no treatment was 21.38, with Z 5 26.43, p < .05, 95% CI [21.80,
20.96]. For reminiscence therapy as compared with no treatment, the estimated
mean SMD was 20.53, with Z 5 22.24, p < .05, 95% CI [21.0, 20.07]. The difference between the mean SMD for cognitive–behavioral therapy compared with
no treatment and that for reminiscence therapy compared with no treatment was
2.84, with Z 5 22.71, p < .05, 95% CI [21.46, 20.23]. This statistically signiﬁcant
difference covered about 3.0 SDs in the Lipsey and Wilson (1993) reﬁned distribution.
Results for Measurement Scenario 2B. The estimated s2 was .094, s 5 .306, and the
estimated I2 was 46.1%. The estimated mean SMD for cognitive–behavioral therapy
as compared with no treatment was 2.59, with Z 5 23.16, p < .05, 95% CI [20.96,
20.23]. For reminiscence therapy as compared with no treatment, the estimated
mean SMD was 20.55, with Z 5 22.65, p < .05, 95% CI [20.96, 20.14]. The estimated difference between the mean SMD for cognitive–behavioral therapy compared with no treatment and that for reminiscence therapy compared with no
treatment was 2.04, with Z 5 0.15, p > .05, 95% CI [20.57, 0.49]. This statistically
nonsigniﬁcant difference covered only about .14 SDs in the Lipsey and Wilson
(1993) reﬁned distribution.
Results for Measurement Scenario 3A. The estimated s2 was .198, s 5 0.445, and
the estimated I2 was 63.0%. The estimated mean SMD for cognitive–behavioral therapy as compared with no treatment was 21.31, with Z 5 25.67, p < .05, 95%
CI [21.76, 20.86]. For reminiscence therapy as compared with no treatment, the estimated mean SMD was 20.57, with Z 5 22.13, p < .05, 90% CI [21.10, 20.05]. The
difference between the estimated mean SMD for comparing cognitive–behavioral
therapy with no treatment and that for comparing reminiscence therapy with no
treatment (2.74) was statistically signiﬁcant, Z 5 22.14, p < .05, 95% CI [21.42,
20.06]. This statistically signiﬁcant difference covered about 2.6 SDs in the Lipsey
and Wilson (1993) reﬁned distribution.
Results for Measurement Scenario 3B. In this measurement scenario, we estimated s2 to be .103, s 5 .32; I2 was 48.5%. The estimated mean SMD for cognitive–
behavioral therapy as compared with no treatment was 2.63, with Z 5 23.31, p <
.05, 95% CI [21.01, 20.26]. For reminiscence therapy compared with no treatment,
the estimated mean SMD was 2.53, with Z 5 22.50, p < .05, 95% CI [20.95, 20.11].
The difference between the estimated mean SMD for comparing cognitive–behavioral
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therapy with no treatment and that for comparing reminiscence therapy with no
treatment (2.10) was statistically nonsigniﬁcant, Z 5 2.36, p > .05, 95% CI [20.64,
0.44]. This statistically nonsigniﬁcant difference covered .36 SDs in the Lipsey and
Wilson (1993) reﬁned distribution.

Comparison of Results Between Measurement Scenarios
First, in all ﬁve measurement scenarios the meta-analytic results suggested cognitive–
behavioral therapy as superior to no treatment for decreasing depression in
older adults. In terms of magnitude, for the exact same group of comparisons of
cognitive–behavioral therapy with no treatment, the magnitude of the estimated
mean SMDs ranged from 2.59 to 21.38. In terms of the Lipsey and Wilson (1993)
reﬁned distribution of mean SMDs, this range covered about 2.8 SDs. Referenced
to the mean of the Lipsey and Wilson (1993) reﬁned distribution, these mean SMDs
ranged from 1.43 SDs to 13.25 SDs above the mean ES.
The smallest differences between estimated mean SMDs for comparing cognitive–
behavioral therapy with no treatment were between the interchangeable Scenarios 2A
and 3A (2.07; 0.25 SD in the Lipsey & Wilson reﬁned distribution), and between 2B
and 3B (0.04; 0.14 SD in the Lipsey & Wilson distribution). In contrast, the largest differences were between the noninterchangeable scenarios 2A and 2B (2.79; 2.8 SD in
the Lipsey & Wilson distribution); 2A and 3B (2.75; 2.7 SD in the Lipsey & Wilson
distribution); 3A and 2B (2.72; 2.6 SD in the Lipsey & Wilson distribution); and 3A
and 3B (2.68; 2.4 SD in the Lipsey & Wilson distribution). The small degree of overlap
of the 95% CIs for the estimated mean SMDs for scenarios 2A and 2B, 3A and 2B, 2A
and 3B, and 3A and 3B suggested that these differences might be statistically significant (Cumming, 2012), though we could not test this. These ﬁndings are consistent
with our hypothesis and with Nugent’s (2012, 2013) speculation that mean SMDs—
for the same group of studies when based on scores from different measures violating CE and ER—could vary substantially.
Second, in all ﬁve measurement scenarios, the meta-analytic results suggested
that reminiscence therapy was better than no treatment for reducing depression
in older adults. For this exact same group of comparisons, the estimated mean SMDs
ranged from 2.53 to 2.57. In terms of the Lipsey and Wilson (1993) reﬁned distribution of mean SMDs, this range covered only about 0.14 SDs. Referenced to the mean
of the Lipsey and Wilson reﬁned distribution, these mean SMDs ranged from .21 to
.36 SDs above the mean ES. The 95% CIs for these estimated mean SMDs all overlapped substantially (see Figure 1), suggesting that none differed to a statistically signiﬁcant degree. These estimated mean SMDs were far less variable across the different measurement scenarios than those for the comparisons of cognitive–behavioral
therapy with no treatment. This lower variability is consistent with Nugent’s (2012,
2013) conjecture that SMDs based on scores from measures meeting CE and ER will
not vary to a signiﬁcant degree.
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Two of the ﬁve comparisons of the estimated mean SMDs for comparing cognitive–
behavioral therapy and no treatment with the estimated mean SMDs for comparing reminiscence therapy and no treatment—those for measurement scenarios 2A
and 3A—suggested that cognitive–behavioral therapy may have statistically signiﬁcant larger magnitude reductions in depression for older adults than reminiscence
therapy. The differences between these mean SMDs covered 3.0 and 2.6 SDs, respectively, in the Lipsey and Wilson (1993) reﬁned distribution. These differences were
of statistical and practical signiﬁcance.

Sensitivity Analyses
As mentioned earlier, we conducted secondary analyses using correlations between
measures of .70 when estimating variances of estimated SMDs that were averages.
We conducted analyses a second time to assess the sensitivity of the previous results, based on these correlations set at .90, to what these correlations were assumed
to be. The results of these sensitivity analyses did not differ signiﬁcantly from the
previous results and are not reported here.

Discussion
In a real-data situation for a given set of studies, the results demonstrated the existence of plausible alternate measurement scenarios in which scores from different
measures appeared to violate CE and ER; as a consequence, meta-analyses based on
the different measurement scenarios produced results that differed to statistically
and practically signiﬁcant degrees. The results shown in Figure 1 reveal signiﬁcant
variability in estimated mean true SMDs for cognitive–behavioral therapy compared with no treatment; results also show signiﬁcant variability in estimated differences between mean SMDs for comparing cognitive–behavioral therapy with
no treatment and mean SMDs for comparing reminiscence therapy with no treatment between different measurement scenarios. The estimated mean true SMDs
for comparing reminiscence therapy with no treatment were quite consistent and
showed relatively low variability across measurement scenarios. The set of seven estimated SMDs for comparisons of cognitive–behavioral therapy with no treatment
were not interchangeable between measurement scenarios, but all four estimated
SMDs for the comparisons of reminiscence therapy with no treatment were interchangeable. Thus, the differences in variability of results appears to be associated
with whether the scores from the different measures the estimated SMDs were
based on met CE and ER and were interchangeable.
As noted earlier, Nugent (2012, 2013) had speculated that meta-analytic results
were most likely to differ between measurement scenarios when large differences
existed between the estimated SMDs for any study (i) based on scores from different
measures as a consequence of violations of CE and ER, and when a substantial per-
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centage of the studies in a meta-analysis exhibited these large differences. These
circumstances held for the measurement scenarios in this study. Eighty-six percent
of the estimated SMDs for comparisons of cognitive–behavioral therapy with no
treatment exhibited such large differences between measurement scenarios, and
these differences appeared to be associated with violations of CE and ER. Thus, the
measurement dependence of the foregoing meta-analytic results appears to have
been associated with the conditions Nugent (2012, 2013) hypothesized.
The measurement scenarios were eminently plausible. All the measures used in
the studies from the Peng et al. (2009) meta-analysis were well established and commonly used measures of depression. The use of estimated SMDs based on single
measures in Scenarios 2A and 2B, and in some cases in 3A and 3B, assumed that
researchers chose to use only a single measure of depression. This would be a plausible methodological choice. For example, such a choice might be made when multiple measures of other constructs are going to be used in a planned study and use
of a single measure of depression will reduce the likelihood of measurement fatigue. Similarly, the use of averages of estimated SMDs based on multiple measures
used in Scenarios 3A and 3B presumed that researchers chose to use multiple measures of depression. Such a choice would also be reasonable. For example, the use
of the Hamilton Rating Scale, a clinician rating scale, and concomitant use of either
the Geriatric Depression Scale or the Beck Depression Inventory, both self-report
scales, could readily be conceptualized as a multimethod measurement strategy.
These ﬁndings conﬁrm Nugent’s (2013, 2017) model-based simulation results.
The results of the current study, as well as the prior research by Nugent (2012, 2013,
2017), extend the literature on the importance of measurement equivalence (e.g.,
Chen, 2008; Vandenberg & Lance, 2000). The results of the current study suggest that
measurement equivalence not only concerns the integrity of results from individual
studies in which, for example, the means of different groups are compared, but also
the validity of meta-analytic results.
The foregoing considerations concern the existence of counterfactual measurement scenarios involving plausible measures not used by researchers in their studies and the possibility that meta-analyses of the same studies, but based on alternate
measurement scenarios, might produce different results. The concern is that the results of meta-analyses may be measurement dependent unless the scores from all of
the measures in a set that researchers might justiﬁably use meet the form of measurement equivalence deﬁned by CE and ER. It should also be noted the results of
the current study, as well as Nugent’s (2013, 2017) previous research, are relevant
for situations in which researchers use multiple measures of a construct—so there
are multiple estimated ESs for a given treatment comparison—yet meta-analysts select only one, or a subset of the estimated ESs to include in a meta-analysis. Such
practices may also lead to measurement-dependent results of meta-analyses.

184

Journal of the Society for Social Work & Research

Spring 2019

The ﬁndings of the current study pertain to circumstances in which the measures used in studies in a meta-analysis have arbitrary metrics and fail to meet CE
and ER. These problems are most likely to be a concern for social work, psychiatric,
psychological, and behavioral meta-analyses of studies of treatments for mental
health, substance abuse, and behavioral problems because measures with arbitrary metrics are frequently used in such studies (Blanton & Jaccard, 2006; Kazdin,
2006).
Along with Nugent’s (2013, 2017) prior work, the results of the current study
suggest that the we must use caution in interpreting the results of meta-analyses
in which the ESs are based on scores from measures with arbitrary metrics that
fail to meet the measurement equivalence deﬁned by CE and ER. The meta-analyst
or social work practitioner who is a consumer of meta-analytic results will need
to carefully investigate the nature of the measures on which the ESs in the metaanalysis are based. When at least some of the measures that the ESs are based on
have arbitrary metrics, and when they do not meet the form of measurement equivalence deﬁned by CE and ER, the results of the meta-analysis may be valid only for
the particular measurement scenario upon which the meta-analysis was based. Had
the ESs in the included studies been based on scores from different but defensible
measures, the results could have been quite different—perhaps with contradictory
ﬁndings and implications.
The methodology of the current study might be considered as a form of sensitivity analysis of the results of a meta-analysis. As was done in this study, the ESs in a
meta-analysis in which at least some of the studies used multiple measures of the
same construct can be subjected to secondary analyses based on different measurement scenarios. The results may offer insight into the degree of measurement dependence for meta-analysis results.
Finally, this study is a single empirical demonstration of the measurement dependence of meta-analytic results. These ﬁndings do not address the frequency
with which measurement-dependent meta-analytic results actually occur. Further
research on this topic is needed.
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